Back to Journals » International Journal of Nanomedicine » Volume 6

Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice

Authors Xu N, Gu JL, Zhu YJ, Wen H, Ren QS, Chen JH

Published 28 April 2011 Volume 2011:6 Pages 905—913

DOI https://doi.org/10.2147/IJN.S17503

Review by Single-blind

Peer reviewer comments 4

Nan Xu1,2, Julin Gu3, Yuanjie Zhu3, Hai Wen3, Qiushi Ren1, Jianghan Chen3
1Institute for Laser Medicine and Biophotonics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, People's Republic of China; 2Department of Dermatology, Shanghai East Hospital, Shanghai, People's Republic of China; 3Department of Dermatology, Shanghai Changzheng Hospital, Shanghai, People's Republic of China

Abstract: Amphotericin B deoxycholate (AmB), a classic antifungal drug, remains the initial treatment of choice for deep fungal infections, but it is not appropriate for treatment of cryptococcal meningitis due to its inability to pass through the blood–brain barrier (BBB). We examined the efficacy of amphotericin B-polybutylcyanoacrylate nanoparticles (AmB-PBCA-NPs) modified with polysorbate 80 that had a mean particle diameter less than 100 nanometers (69.0 ± 28.6 nm). AmB-PBCA-NPs were detected in the brain 30 minutes after systemic administration into BALB/c mice and had a higher concentration than systemically administered AmB liposome (AmB-L, P < 0.05); AmB was not detected in the brain. Following infection for 24 hours and then 7 days of treatment, the survival rate of mice in the AmB-PBCA-NP group (80%) was significantly higher than that of the AmB (0%) or AmB-L (60%) treatment groups. Fungal load was also lower when assessed by colony-forming unit counts obtained after plating infected brain tissue (P < 0.05). Our study indicates that AmB-PBCA-NPs with polysorbate 80 coating have the capacity to transport AmB across the BBB and is an efficient treatment against cryptococcal meningitis in a mouse model.

Keywords: cryptococcal meningitis, polybutylcyanoacrylate (PBCA), nanoparticles, brain targeting

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Grafting of a novel gold(III) complex on nanoporous MCM-41 and evaluation of its toxicity in Saccharomyces cerevisiae

Fazaeli Y, Amini MM, Ashourion H, Heydari H, Majdabadi A, Jalilian AR, Abolmaali S

International Journal of Nanomedicine 2011, 6:3251-3257

Published Date: 12 December 2011

The efficacy of mitochondrial targeting antiresistant epirubicin liposomes in treating resistant leukemia in animals

Men Y, Wang XX, Li RJ, Zhang Y, Tian W, Yao HJ, Ju RJ, Ying X, Zhou J, Li N, Zhang L, Yu Y, Lu WL

International Journal of Nanomedicine 2011, 6:3125-3137

Published Date: 2 December 2011

Biosynthesis of gold nanoparticles using chloroplasts

Zhang YX, Zheng J, Gao G, Kong YF, Zhi X, Wang K, Zhang XQ, Cui DX

International Journal of Nanomedicine 2011, 6:2899-2906

Published Date: 21 November 2011

Treatment of oral squamous cell carcinoma using anti-HER2 immunonanoshells

Fekrazad R, Hakimiha N, Farokhi E, Rasaee MJ, Ardestani MS, Kalhori KA, Sheikholeslami F

International Journal of Nanomedicine 2011, 6:2749-2755

Published Date: 9 November 2011

Biocompatibility of Fe3O4@Au composite magnetic nanoparticles in vitro and in vivo

Li Y, Liu J, Zhong Y, Zhang J, Wang Z, Wang L, An Y, Lin M, Gao Z, Zhang D

International Journal of Nanomedicine 2011, 6:2805-2819

Published Date: 9 November 2011

Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells

Mura S, Hillaireau H, Nicolas J, Le Droumaguet B, Gueutin C, Zanna S, Tsapis N, Fattal E

International Journal of Nanomedicine 2011, 6:2591-2605

Published Date: 26 October 2011

Physicochemical properties and biocompatibility of a polymer-paclitaxel conjugate for cancer treatment

Yang D, Van S, Liu J, Wang J, Jiang X, Wang Y, Yu L

International Journal of Nanomedicine 2011, 6:2557-2566

Published Date: 21 October 2011

Microencapsulation of nanoemulsions: novel Trojan particles for bioactive lipid molecule delivery

Li X, Anton N, Ta TMC, Zhao M, Messaddeq N, Vandamme TF

International Journal of Nanomedicine 2011, 6:1313-1325

Published Date: 24 June 2011

Reversible exposure of hydrophobic residues on albumin as a novel strategy for formulation of nanodelivery vehicles for taxanes

Garro AG, Beltramo DM, Alasino RV, Leonhard V, Heredia V, Bianco ID

International Journal of Nanomedicine 2011, 6:1193-1200

Published Date: 13 June 2011

The changes of T lymphocytes and cytokines in ICR mice fed with Fe3O4 magnetic nanoparticles

Wang J, Chen B, Jin N, Xia G, Chen Y, Zhou Y, Cai X, Ding J, Li X, Wang X

International Journal of Nanomedicine 2011, 6:605-610

Published Date: 1 April 2011